Inventor
GLEBOCKA AGNIESZKA
US18 patents
⚠️ This page may combine multiple inventors who share the name “GLEBOCKA AGNIESZKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WISCONSIN ALUMNI RES FOUND
8 patentsUS7763598B2Jul 27, 2010
1α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain
WISCONSIN ALUMNI RES FOUND5 citations63
US7538098B2May 26, 2009
19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring
WISCONSIN ALUMNI RES FOUND2 citations63
US7241747B2Jul 10, 2007
2-propylidene-19-nor-vitamin D compounds
WISCONSIN ALUMNI RES FOUND4 citations63
US7879829B2Feb 1, 2011
19-nor-vitamin D analogs with 1,2-dihydrofuran ring
WISCONSIN ALUMNI RES FOUND2 citations61
US7648974B1Jan 19, 2010
19-nor-vitamin D analogs with 3,2-dihydrofuran ring
WISCONSIN ALUMNI RES FOUND5 citations61
US7943601B2May 17, 2011
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs
WISCONSIN ALUMNI RES FOUND1 citations52
US7531527B2May 12, 2009
2-Propylidene-19-nor-vitamin D compounds
WISCONSIN ALUMNI RES FOUND0 citations52
US8785422B2Jul 22, 2014
A-ring modified 19-nor-vitamin D analogs and their uses
WISCONSIN ALUMNI RES FOUND0 citations42
ARROWHEAD PHARMACEUTICALS INC
7 patentsUS10294474B2May 21, 2019
Targeting ligands
ARROWHEAD PHARMACEUTICALS INC15 citations84
US11180529B2Nov 23, 2021
Alpha-v beta-6 integrin ligands and uses thereof
ARROWHEAD PHARMACEUTICALS INC3 citations71
US11174481B2Nov 16, 2021
Targeting ligands
ARROWHEAD PHARMACEUTICALS INC3 citations71
US12173086B2Dec 24, 2024
Alpha-v beta-6 integrin ligands and uses thereof
ARROWHEAD PHARMACEUTICALS INC0 citations60
US12551569B2Feb 17, 2026
RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations56
US12527877B2Jan 20, 2026
Anti-transferrin receptor antibodies, conjugates thereof, and uses thereof
ARROWHEAD PHARMACEUTICALS INC0 citations49
US12442002B2Oct 14, 2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations44
DELUCA HECTOR F
3 patentsUS8519169B2Aug 27, 2013
Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3
DELUCA HECTOR F2 citations61
US8058265B2Nov 15, 2011
1a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof
DELUCA HECTOR F1 citations52
US8217023B2Jul 10, 2012
19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
DELUCA HECTOR F0 citations42